To accelerate the translation of ATP-Bio innovations into real-world impact by fostering a dynamic ecosystem of researchers, entrepreneurs, and industry partners.
A thriving biopreservation innovation network that bridges discovery and deployment—advancing technologies that benefit health, sustainability, and society.
Drive early-stage commercialization by increasing technology readiness, strengthening partnerships, and expanding entrepreneurial support.
The Strategic Priorities of the Engineering Workforce Development Program are tied to the above strategy.
Regenerative medicine, aquaculture, and other industries related to ATP-Bio are worth over $300B globally and are predicted to grow substantially by 2027.
Solid Organs / Tissues and Aquaculture markets are larger, more mature,with less growth. They are ripe for disruption from new technologies such as ATP-Bio. Regenerative medicine and cell therapies and MPS are emerging markets, with huge growth potential, and where ATP-Bio technologies can have a dramatic impact on that growth. ATP-Bio technologies are poised to improve all four of these markets, and thereby save more lives and feed more people.
